Where EHS Investment, Innovation & Real-World Need Converge
The 3rd EHS for Biopharma Summit was the only meeting built specifically for the realities of EHS in drug development - where leaders were under pressure to do more with leaner teams, manage unfamiliar risks, and enable growth without compromising safety or productivity.
This audience was not looking for generic solutions. They were actively reassessing how they manage EHS as biopharma scales into new modalities, facilities, and geographies, and they are looking for partners who understand their constraints, not just their regulations.
For service providers, this summit offers a rare opportunity to engage senior EHS decision-makers at the point where strategy, budget, and operational reality meet.
What was Expected in 2026?
Showcase Digital Intelligence & Predictive Safety
Position your EHS software, AI, and engineering tools at the centre of biopharma’s digital evolution. With senior decision-makers seeking smarter ways to anticipate risk, streamline compliance, and unify data, the summit offers a platform to demonstrate how your technology powers real-time visibility and data-driven safety excellence.
Empower People, Culture & Compliance
Engage directly with leaders prioritising workforce wellbeing, leadership development, and behavioural accountability. Showcase your consulting, training, or ergonomic solutions as the bridge between safety systems and the human factors that drive sustainable, measurable performance improvements.
Advance Sustainable, Safe & Future-Ready Operations
Biopharma companies are investing in climate-conscious facilities and resilient safety frameworks. Align your containment, wastewater, or contractor management innovations with their sustainability goals - from carbon reduction and waste recovery to adaptive lab design and global compliance integration.
Connect Where EHS Investment Decisions Are Made
Meet the industry’s most progressive EHS leaders - from Global Heads to Site Directors - representing the companies investing most in safety, digitalisation, and sustainable growth. Build relationships, uncover partnership opportunities, and position your brand as a trusted solution provider shaping the next era of biopharma EHS.
Hear What Our Past Sponsors Have to Say
The attendees were well prepared and it was a very collaborative event
Jon Zibell, Vice President - Global Alliances & Marketing, SciShield
Given the smaller size of the event, we had the opportunity to speak to everyone in attendance
Daniel Jameson, Director - Business Development, ILC Dover
Attending Companies Included